Ignite Creation Date:
2025-12-25 @ 4:13 AM
Ignite Modification Date:
2025-12-26 @ 3:13 AM
Study NCT ID:
NCT06094920
Status:
ENROLLING_BY_INVITATION
Last Update Posted:
2025-04-22
First Post:
2023-10-11
Is NOT Gene Therapy:
False
Has Adverse Events:
False
Brief Title:
Treatment Optimization for Patients With Type 2 Diabetes Using Empagliflozin and Finerenone in a Remote Clinical Trial
Sponsor:
University Medical Center Groningen
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2024-08-05
Start Date Type:
ACTUAL
Primary Completion Date:
2025-06-01
Primary Completion Date Type:
ESTIMATED
Completion Date:
2025-10-30
Completion Date Type:
ESTIMATED
First Submit Date:
2023-10-11
First Submit QC Date:
None
Study First Post Date:
2023-10-23
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2025-04-16
Last Update Post Date:
2025-04-22
Last Update Post Date Type:
ACTUAL